Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

241
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
241
Clinical Trials: Overview01:11

Clinical Trials: Overview

2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

439
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
439

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Frequency and characteristics of multi-domain autonomic dysfunction in patients with spontaneous intracranial hypotension.

Headache·2026
Same author

Surgical Treatment of Spontaneous Intracranial Hypotension: Clinical Characteristics and Outcomes in a Surgically Treated Cohort of Type 1 and Type 3 Leaks.

Journal of clinical medicine·2026
Same author

Real-world effectiveness and safety of CGRP monoclonal antibodies in elderly migraine patients: a Korean multicenter study.

The journal of headache and pain·2026
Same author

Stage-specific polysomnographic and MRI markers across phenoconversion in isolated REM sleep behavior disorder.

Journal of neurology·2026
Same author

Event-level nocturnal blood pressure dynamics in obstructive sleep apnea assessed by cuffless monitoring.

Sleep·2026
Same author

Use of CGRP Monoclonal Antibodies in Japan, South Korea, and Taiwan: A Narrative Review.

Current pain and headache reports·2026

Related Experiment Video

Updated: Jun 17, 2025

Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

21.9K

Trends in Triptan Usage in Korea: A Population-Based Cohort Study.

Woo-Seok Ha1, JaeWook Jeong1, Seungwon Song1

  • 1Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.

Journal of Korean Medical Science
|August 13, 2024
PubMed
Summary

Migraine treatment with triptans is increasing in Korea, but still underutilized. Neurologists prescribe triptans more often than other specialists, indicating a need for broader migraine management strategies.

Keywords:
Drug TherapyMigraine DisordersSerotonin 5-HT1 Receptor AgonistsTreatment OutcomeTriptans

More Related Videos

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

18.2K
Minimally Invasive Thumb-sized Pterional Craniotomy for Surgical Clip Ligation of Unruptured Anterior Circulation Aneurysms
11:58

Minimally Invasive Thumb-sized Pterional Craniotomy for Surgical Clip Ligation of Unruptured Anterior Circulation Aneurysms

Published on: August 11, 2015

15.5K

Related Experiment Videos

Last Updated: Jun 17, 2025

Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

21.9K
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

18.2K
Minimally Invasive Thumb-sized Pterional Craniotomy for Surgical Clip Ligation of Unruptured Anterior Circulation Aneurysms
11:58

Minimally Invasive Thumb-sized Pterional Craniotomy for Surgical Clip Ligation of Unruptured Anterior Circulation Aneurysms

Published on: August 11, 2015

15.5K

Area of Science:

  • Neurology
  • Pharmacology
  • Public Health

Background:

  • Migraine is a significant global health issue requiring effective acute treatments.
  • Triptans offer improved migraine management compared to traditional medications.
  • Limited data exists on triptan use in Asian populations, who may experience milder symptoms.

Purpose of the Study:

  • To investigate trends in triptan usage for migraine management in Korea.
  • To analyze prescription patterns and factors influencing triptan prescription.

Main Methods:

  • Retrospective cohort study using Korean National Health Insurance Service data (2002-2019).
  • Analysis of triptan prescription quantity, pills per patient, costs, and distribution across medical specialties.
  • Multivariable logistic regression to identify factors associated with triptan prescription.

Main Results:

  • Triptan use (tablets, prescriptions, patients) increased significantly from 2002-2019.
  • Sumatriptan was the most prescribed triptan; prescription costs rose despite stable pricing.
  • By 2019, only about 10% of migraine patients received triptans, with higher prescription rates by neurologists compared to general practitioners.

Conclusions:

  • Triptan use in Korean migraine patients is increasing, mirroring global trends.
  • Overall triptan prescription rates remain low, suggesting potential underutilization.
  • Improved migraine management strategies and optimized triptan utilization are needed across medical fields.